The goal of this study is to conduct a Type 1 hybrid effectiveness-implementation study of seven jails in Massachusetts that deliver all FDA-approved MOUDs (naltrexone, buprenorphine, methadone) to produce findings with implications for policies for OUD in criminal justice settings. This research will focus on (1) post-release recidivism, overdoses, and MOUD initiation, engagement, and retention, (2) factors that facilitate and impede MOUD delivery in jails and within communities, and (3) cost and economic evaluation of implementation.
Associated JCOIN Study Title: Evaluation of Massachusetts Policy Mandating all Medication for Opioid Use Disorders in Jails (032)
Publication Year: 2021
Lead Author: Elizabeth Evans
Journal: Journal of Substance Abuse Treatment
Publication Type(s): Protocol Paper
JCOIN Hub/Center: Baystate Hub